Director, Access International Oncology
Director, Access International Oncology
Employer Active
Job Alert
You will be updated with latest job alerts via email
Share
Job Alert
You will be updated with latest job alerts via email
Not Disclosed
Salary Not Disclosed
1 Vacancy
Job Description
Band
Level 6Job Description Summary
Access Directors are dedicated to codeveloping innovative and winning market access strategies optimizing the payer value proposition and accessrelevant evidence packages for assets in partnership with the CLS and cross functional teams.They develop and implement transformative access solutions serving strategic disease areas (DAs) and maximizing IM assets with focus on our priority geographic markets (CN DE JP) major HTA archetypes (e.g. UK/CAN) and
Budget Impact archetypes (e.g. Italy/Spain) needs and feasibility.
Access Directors
Represent access with internal partners and external stakeholders. Internally drive vision inspire and provide leadership throughout the Access community (International Regions Countries) and with key partners (CPS/International Development Biomedical Research Operations S&G Regions and Countries). Externally represent Novartis in appropriate fora and organizations to drive the Novartis strategic access agenda.
With International TA develop and deliver all aspects of access strategy and execution for compounds/brands across the RDC continuum.
Collaborate and partner with TAs Medical Affairs Development and Biomedical Research to enhance the value proposition access strategy and accessrelevant evidence packages. Ensure access landscaping and payer evidence requirements are built into TPPs clinical development plans integrated product strategies indication sequencing/asset maximization.
Enable asset strategy to translate science into payer and HCS value propositions and solutions securing access affordability and contribute to wide scale patient access and efficiencies at scale.
With CLS and Pricing team (co)create the international pricing strategy and guidance.
With CLS generate payer negotiation strategy upskill and prepare countries for their payer negotiations.
With CLS create innovative patient access and contracting approaches Managed Entry Agreements (MEAs) and Patient Support Programs (PSPs) as required to improve patient outcomes and support healthcare system affordability.
Ensure the appropriate and timely access inputs into IEPs IPS asset maximization incl. indication sequencing.
Create collaborative partnerships internally and externally to break down silos partner across the value chain and shape the future of healthcare and markets.
Manage resource requirements to address asset/DA priorities.
Job Description
Key Responsibilities:
- Developing and operationalizing the Integrated Product Access strategy. Create and champion a compelling and competitive international strategic vision for how IM will innovate and expand access through DAs for the benefit of patients Healthcare Systems Payers and Novartis
- Active leadership to enable broad country insights and alignment and leverage external fora ( & advisory boards) to pressuretest strategies level of evidence etc. for feasibility and success
- With the TA develop the international integrated product access strategy (IPAS) to deliver product differentiation most relevant to payers (e.g. welldefined target population clinical endpoints comparators outcome measures utility instruments Health Economics data) patients and HCS stakeholders worldwide.
- Ensure that at launch Novartis brands are supported by a robust payer value proposition particularly featuring core elements; Value for money story strong value evidence package and a pricing strategy maximizing the lifetime value of the brand (including existing and future evidence to justify price) and the reputation of Novartis.
- Ensure access team develops and represents expert value evidence input into TPPs clinical programs (including IEPs) BD&Ls and develop any additional nonregistration evidence to meet the needs of medical experts and institutions involved in reimbursement & access decisions for key geographies.
- Collaborate with the HEOR & PCO team to ensure full integration of adequate HEOR/evidence deliverables in high quality crossfranchise strategy. Ensure appropriate focus on priority markets needs into overall strategy. Ensure appropriate and timely access input into BD&Ls asset maximization incl. indication sequencing. Maximize value of IM assets by creating and executing together with TAs & pricing team winning pricing strategies global pricing guidance incl. MEAs PSPs rigorous international pricing governance.
- Determine payer evidence requirements risks/opportunities in the access landscape and create compelling access strategy with the TA and provide the access toolbox to share with priority markets (CN DE JP) major HTA archetypes (e.g. UK/CAN) and Budget Impact archetypes (e.g. Italy/Spain)
- Stay abreast of internal and external developments trends and other dynamics that affect the wider health policy and access domains as well as of relevant scientific clinical and commercial developments. Analyse and anticipate changes in priority international markets (CN DE JP) major HTA archetypes ( and Budget Impact archetypes (e.g. Italy/Spain) to model future expenditures and project critical market access assumptions.
- Collaborate with S&G and Development to drive consistent and accessoptimal approaches to product shaping value propositions and HCS value creation. Disseminate value of medicines to HCS decisionmakers with focus on international forums and publications in collaboration with international or regional policy groups.
- Manage Access community and budgets. Effectively work in matrix balancing crossfunctional perspectives and alignment with business priorities against flexible resourcing.
Essential requirements:
- 5 years of experience in market access roles
- 2 years global or exUS regional experience
- Experience working early in drug development lifecycle
- Product launch experience
- Cross functional and matrix influential experience across a team of multiple stakeholders
- Experience in driving commercial strategy driven through access or HEOR or pricing expertise
Desirable requirements:
- MBA Ph.D. M.D. or RPh. Experience in Oncology
- 7 years of experience in market access roles. 5 years global or exUS regional experience. ExUS country experience. 2 years of experience in the relevant therapeutic area
Location: This role is based in Basel Switzerland.
Benefits: Read our handbook to learn about all the ways well help you thrive personally and professionally: Novartis Life Handbook
Commitment to Diversity & Inclusion: Novartis is committed to building an outstanding inclusive work environment and diverse teams representative of the patients and communities we serve.
Accessibility and accommodation: Novartis is committed to working with and providing reasonable accommodation to all individuals. If because of a medical condition or disability you need a reasonable accommodation for any part of the recruitment process or in order to receive more detailed information about the essential functions of a position please send an email to and let us know the nature of your request and your contact information. Please include the job requisition number in your message.
Skills Desired
Access And Reimbursement Strategy Access And Reimbursement Strategy Agility Analytical Skill Analytical Thinking CrossFunctional Collaboration CustomerCentric Mindset Employee Development Finance GoToMarket Strategy Healthcare Sector Understanding Health Economics Health Policy Health Technology Assessment (HTA) Influencing Skills Innovation Inspirational Leadership Lcm Strategy Market Access Strategy Negotiation Skills People Management Pricing Strategy Process Management Product Launches Public Affairs 7 moreRequired Experience:
Director
Employment Type
Full-Time
